Table 3 Frequency of DRE and PSA based screening by location of practice and gender for patients aged 40 to 69
From: Prostate cancer screening in Primary Health Care: the current state of affairs
Every year | Every 2 years | Every 5 years | Would not recommend | P value | Other/not answered | |
|---|---|---|---|---|---|---|
DRE | ||||||
Setting | 0.194 | |||||
Metro GP (%) | 25 (34.3) | 25 (34.3) | 8 (11.0) | 15 (20.5) | 20 | |
Rural GP | 6 (22.2) | 8 (29.6) | 7 (25.9) | 6 (22.2) | 28 | |
Gender | 0.388 | |||||
Female GP (%) | 10 (32.3) | 12 (38.7) | 5 (16.1) | 4 (12.9) | 12 | |
Male GP (%) | 21 (31.3) | 19 (28.4) | 10 (14.9) | 17 (25.4) | 35 | |
PSA | ||||||
Setting | 0.006 | |||||
Metro GP (%) | 35 (49.3) | 15 (21.1) | 7 (9.9) | 14 (19.7) | 22 | |
Rural GP (%) | 7 (18.4) | 14 (36.8) | 4 (10.5) | 13 (34.2) | 17 | |
Gender | 0.434 | |||||
Female GP (%) | 10 (30.3) | 9 (27.3) | 7 (21.2) | 7 (21.2) | 10 | |
Male GP (%) | 31 (41.9) | 19 (25.7) | 4 (5.4) | 20 (27.0) | 28 | |